GlassScriptPhysician profile
Linda Egan
NPI 1104255074
$805.97
in general payments reported to CMS, 2019-2025
14 companies · $72.09 in 2025
The $72.09 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $156 · 2022: $171 · 2023: $296 · 2024: $111 · 2025: $72.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $479.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $144.95 | 2021-2023 | |
| Hologic Sales and Service, LLC | $105.95 | 2023-2025 | Fluent Fluid Management System, Novasure, Myosure Tissue Removal Device |
| Astellas Pharma US INC | $82.44 | 2022-2023 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $62.54 | 2021-2024 | Slynd |
| Myovant Sciences INC. | $54.82 | 2022 | |
| Mayne Pharma Commercial LLC | $48.82 | 2022 | |
| Sumitomo Pharma America, INC. | $47.78 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $47.68 | 2023 | |
| Pfizer INC. | $45.17 | 2021-2023 | |
| Sage Therapeutics, LLC | $42.58 | 2024 | |
| Coopersurgical, INC. | $39.35 | 2023 | Paragard T 380a |
| Millicent US INC | $38.38 | 2023-2024 | Intrarosa, Femring |
| Shield Therapeutics INC | $23.88 | 2024 | |
| Evofem Biosciences, INC. | $21.63 | 2023 | Phexxi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Egan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.